Article 1
The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.
Commission Regulation (EU) 2015/1041 of 30 June 2015 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health (Text with EEA relevance)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Rejected health claims Application — Relevant provisions of Regulation (EC) No 1924/2006 Nutrient, substance, food or food category Claim EFSA opinion reference Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data. Citrulline-malate Maintenance of ATP levels through reduction of lactates in excess for an improved recovery from muscle fatigue. Q-2013-00659 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data. Olive ( Olea europaea L. ) leaf water extract Daily intake of supplemental olive leaf extract polyphenols contributes to the reduction of the blood glucose rise after meals. Q-2013-00783 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data. Pacran ® Pacran ® helps to inhibit the adhesion of P-fimbriated E. coli to the urinary tract cells. Q-2013-00889 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data. A combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 Improves intestinal comfort. Q-2013-00892 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data. A combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 Regulates your (intestinal) transit. Q-2013-00893 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data. A combination of L-threonine, L-valine, L-leucine, L-isoleucine, L-lysine plus chromium picolinate Contributes to the reduction of the blood glucose rise when consumed together with a carbohydrate rich meal. Q-2013-00756 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data. A combination of lutein and zeaxanthin Lutein together with zeaxanthin helps maintain clarity and contrast of sight in bright light conditions. Q-2013-00875
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.